ArticleTranslational cancer research2025

Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm.

Ari A Kassardjian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.